HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shigeru Yamada Selected Research

Knee Osteoarthritis

4/2022The Oral Administration of Highly-Bioavailable Curcumin for One Year Has Clinical and Chondro-Protective Effects: A Randomized, Double-Blinded, Placebo-Controlled Prospective Study.
1/2020The Efficacy and Safety of Highly-Bioavailable Curcumin for Treating Knee Osteoarthritis: A 6-Month Open-Labeled Prospective Study.
11/2014Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shigeru Yamada Research Topics

Disease

55Neoplasms (Cancer)
01/2024 - 09/2002
29Pancreatic Neoplasms (Pancreatic Cancer)
05/2024 - 10/2004
15Rectal Neoplasms (Rectal Cancer)
06/2023 - 12/2004
13Neoplasm Metastasis (Metastasis)
12/2020 - 11/2008
10Carcinoma (Carcinomatosis)
12/2022 - 10/2004
9Hepatocellular Carcinoma (Hepatoma)
03/2024 - 08/2004
9Colorectal Neoplasms (Colorectal Cancer)
09/2023 - 03/2014
6Sarcoma (Soft Tissue Sarcoma)
04/2024 - 11/2002
6Melanoma (Melanoma, Malignant)
07/2022 - 12/2004
5Prostatic Neoplasms (Prostate Cancer)
05/2024 - 10/2004
4Esophageal Squamous Cell Carcinoma
10/2023 - 09/2004
4Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2023 - 06/2006
4Adenoid Cystic Carcinoma (Cylindroma)
01/2023 - 12/2004
4Esophageal Neoplasms (Esophageal Cancer)
11/2022 - 09/2004
4Lymphatic Metastasis
12/2019 - 11/2011
4Mitochondrial Diseases (Mitochondrial Disease)
01/2017 - 08/2015
3Head and Neck Neoplasms (Head and Neck Cancer)
02/2024 - 03/2022
3Lung Neoplasms (Lung Cancer)
01/2024 - 06/2004
3Chordoma
10/2022 - 12/2004
3Cholangiocarcinoma
10/2022 - 04/2021
3Knee Osteoarthritis
04/2022 - 11/2014
3Breast Neoplasms (Breast Cancer)
07/2021 - 01/2006
3Necrosis
01/2021 - 01/2006
3Myasthenia Gravis
04/2012 - 02/2012
3Adenocarcinoma
01/2010 - 12/2004
2Infections
04/2024 - 01/2022
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2024 - 02/2003
2Hypoxia (Hypoxemia)
10/2021 - 01/2011
2Chondrosarcoma
11/2020 - 12/2004
2Chromosome Aberrations (Chromosome Abnormalities)
07/2020 - 06/2004
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
03/2016 - 01/2006
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2012 - 08/2010
2Uterine Neoplasms (Uterine Cancer)
01/2006 - 10/2004
1Fallopian Tube Neoplasms
07/2024
1Ovarian Neoplasms (Ovarian Cancer)
07/2024
1Lymphopenia (Lymphocytopenia)
05/2024
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2024
1Hypothyroidism
06/2023
1Otitis Media with Effusion
01/2023
1Osteoradionecrosis
01/2023
1Stress Fractures (Stress Fracture)
12/2022
1Triple Negative Breast Neoplasms
02/2022
1Inflammation (Inflammations)
01/2022
1COVID-19
01/2022
1Bile Duct Neoplasms (Bile Duct Cancer)
04/2021
1Biliary Tract Neoplasms (Biliary Tract Cancer)
04/2021

Drug/Important Bio-Agent (IBA)

40CarbonIBA
05/2024 - 09/2002
6IonsIBA
01/2021 - 09/2002
6Proteins (Proteins, Gene)FDA Link
07/2020 - 07/2002
4GemcitabineFDA Link
12/2020 - 04/2006
4Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 04/2006
4tributyltinIBA
04/2016 - 05/2013
4AntibodiesIBA
02/2016 - 02/2012
3CurcuminIBA
04/2022 - 11/2014
3Aldehyde DehydrogenaseIBA
01/2022 - 01/2017
3Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
04/2016 - 08/2014
3NAD (NADH)IBA
04/2016 - 08/2014
3muskIBA
04/2012 - 02/2012
2durvalumabIBA
06/2023 - 03/2022
2Cisplatin (Platino)FDA LinkGeneric
06/2023 - 03/2022
2Protons (Proton)IBA
06/2023 - 01/2023
2VaccinesIBA
01/2022 - 01/2017
2DNA (Deoxyribonucleic Acid)IBA
07/2020 - 11/2007
2isocitric acid (isocitrate)IBA
04/2016 - 08/2015
2Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2014 - 11/2014
2rho-Associated KinasesIBA
08/2014 - 04/2011
2Phosphotransferases (Kinase)IBA
04/2012 - 02/2012
2AcetylcholinesteraseIBA
04/2012 - 02/2012
2AutoantibodiesIBA
03/2012 - 02/2012
1GoldIBA
05/2024
1Chir 99021IBA
04/2024
1RNA (Ribonucleic Acid)IBA
04/2024
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
01/2023
1RadiopharmaceuticalsIBA
01/2023
1Oncogene Proteins (Oncogene Protein)IBA
01/2023
1metabotropic glutamate receptor type 1IBA
01/2023
1AndrogensIBA
01/2023
1Methionine (L-Methionine)FDA Link
11/2022
1Ointments (Pastes)IBA
07/2022
1IodineIBA
07/2022
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
02/2022
1lysophosphatidic acidIBA
02/2022
1Vitamin DFDA LinkGeneric
01/2022
1MicronutrientsIBA
01/2022
1Oxygen (Dioxygen)IBA
10/2021
1HeliumIBA
10/2021
1Fingolimod Hydrochloride (FTY720)FDA Link
07/2021

Therapy/Procedure

75Heavy Ion Radiotherapy
07/2024 - 11/2002
31Radiotherapy
07/2024 - 06/2004
31Therapeutics
05/2024 - 10/2004
10Drug Therapy (Chemotherapy)
09/2023 - 08/2010
5Re-Irradiation
07/2024 - 01/2021
4Aftercare (After-Treatment)
06/2023 - 08/2010
3Combined Modality Therapy
06/2023 - 04/2021
3Chemoradiotherapy
03/2022 - 04/2008
3Immunotherapy
01/2018 - 08/2010
2Neoadjuvant Therapy
12/2020 - 06/2012
2Lymph Node Excision (Lymph Node Dissection)
11/2014 - 11/2014
1Proton Therapy
03/2023
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2023